首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC
Authors:Jens Ricke  Karsten Bulla  Frank Kolligs  Markus Peck‐Radosavljevic  Peter Reimer  Bruno Sangro  Eckart Schott  Kerstin Schütte  Chris Verslype  Jerzy Walecki  Peter Malfertheiner  the SORAMIC study group
Affiliation:1. Department of Radiology and Nuclear Medicine, Otto‐von‐Guericke University, Magdeburg, Germany;2. Department of Medicine II, LMU University of Munich, Munich, Germany;3. Internal Medicine III, Department of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria;4. Department of Radiology, Karlsruhe Hospital, Karlsruhe, Germany;5. Liver Unit and HPB Oncology, Clinica Universidad de Navarra, Pamplona, Spain;6. Department of Hepatology and Gastroenterology, Charité University Hospital Berlin, Berlin, Germany;7. Department of Gastroenterology, Hepatology and Infectious Diseases, Otto‐von‐Guericke University, Magdeburg, Germany;8. Department of Hepatology and Digestive Oncology, University Hospital Gasthuisberg, Leuven, Belgium;9. Department of Radiology, MSWiA Hospital Warsaw, Warsaw, Poland
Abstract:
Keywords:   HCC     hepatocellular carcinoma  radioembolization  safety     SIRT     sorafenib  survival  tolerability
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号